Zurück
Nationale Strategie für Gen- und Zellbasierte Therapien (GCT)
12.12.25 bis 25.06.26

Programm GeneNovate 2025/2026

Save the date
© © N-Universe / stock.adobe.com

GeneNovate is the first nationwide entrepreneurship program in Germany, designed to empower innovators and entrepreneurs in the field of Gene and Cell Therapies (GCT), Biotech and Medicine.

Who should apply?

The program targets early-career scientists and physicians, such as PhD candidates, and Postdocs, but it is also open to experienced researchers and medical professionals.

When does it take place?

The GeneNovate program runs from November 2025 to June 2026 and includes a kick-off meeting, six theoretical input sessions (hybrid), six full-day workshops (onsite), team-based preparation and presentation of startup pitches and culminates in the Final Event in Munich.


Kategorien